149 related articles for article (PubMed ID: 28556791)
1. Significance of Phosphorylated Epidermal Growth Factor Receptor and Its Signal Transducers in Human Soft Tissue Sarcoma.
Yang JL; Gupta RD; Goldstein D; Crowe PJ
Int J Mol Sci; 2017 May; 18(6):. PubMed ID: 28556791
[No Abstract] [Full Text] [Related]
2. Overcoming resistance of targeted EGFR monotherapy by inhibition of STAT3 escape pathway in soft tissue sarcoma.
Wang X; Goldstein D; Crowe PJ; Yang M; Garrett K; Zeps N; Yang JL
Oncotarget; 2016 Apr; 7(16):21496-509. PubMed ID: 26909593
[TBL] [Abstract][Full Text] [Related]
3. Expression of epidermal growth factor receptor (EGFR) and activated EGFR predict poor response to (chemo)radiation and survival in cervical cancer.
Noordhuis MG; Eijsink JJ; Ten Hoor KA; Roossink F; Hollema H; Arts HJ; Pras E; Maduro JH; Reyners AK; de Bock GH; Wisman GB; Schuuring E; van der Zee AG
Clin Cancer Res; 2009 Dec; 15(23):7389-97. PubMed ID: 19920104
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylated EGFR at tyrosine 1173 correlates with poor prognosis in oral squamous cell carcinomas.
Monteiro L; Ricardo S; Delgado M; Garcez F; do Amaral B; Lopes C
Oral Dis; 2014 Mar; 20(2):178-85. PubMed ID: 23464360
[TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor receptor blockade in combination with conventional chemotherapy inhibits soft tissue sarcoma cell growth in vitro and in vivo.
Ren W; Korchin B; Zhu QS; Wei C; Dicker A; Heymach J; Lazar A; Pollock RE; Lev D
Clin Cancer Res; 2008 May; 14(9):2785-95. PubMed ID: 18451246
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylated Epidermal Growth Factor Receptor Expression Is Associated With Clinicopathologic Parameters and Patient Survival in Mobile Tongue Squamous Cell Carcinoma.
Theocharis S; Giaginis C; Dana E; Thymara I; Rodriguez J; Patsouris E; Klijanienko J
J Oral Maxillofac Surg; 2017 Mar; 75(3):632-640. PubMed ID: 27657462
[TBL] [Abstract][Full Text] [Related]
7. The epidermal growth factor receptor pathway in relation to pelvic lymph node metastasis and survival in early-stage cervical cancer.
Eijsink JJ; Noordhuis MG; ten Hoor KA; Kok M; Hollema H; de Bock GH; Nijman HW; Schuuring E; Wisman GB; van der Zee AG
Hum Pathol; 2010 Dec; 41(12):1735-41. PubMed ID: 21078436
[TBL] [Abstract][Full Text] [Related]
8. Low HIF-1α and low EGFR mRNA Expression Significantly Associate with Poor Survival in Soft Tissue Sarcoma Patients; the Proteins React Differently.
Rot S; Taubert H; Bache M; Greither T; Würl P; Holzhausen HJ; Eckert AW; Vordermark D; Kappler M
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30513863
[TBL] [Abstract][Full Text] [Related]
9. Expression of the epidermal growth factor receptor (EGFR) and the phosphorylated EGFR in invasive breast carcinomas.
Magkou C; Nakopoulou L; Zoubouli C; Karali K; Theohari I; Bakarakos P; Giannopoulou I
Breast Cancer Res; 2008; 10(3):R49. PubMed ID: 18522728
[TBL] [Abstract][Full Text] [Related]
10. Expression of pEGFR and pAKT as response-predictive biomarkers for RAS wild-type patients to anti-EGFR monoclonal antibodies in metastatic colorectal cancers.
Harlé A; Salleron J; Perkins G; Pilati C; Blons H; Laurent-Puig P; Merlin JL
Br J Cancer; 2015 Aug; 113(4):680-5. PubMed ID: 26171935
[TBL] [Abstract][Full Text] [Related]
11. Dihydrotestosterone upregulates the expression of epidermal growth factor receptor and ERBB2 in androgen receptor-positive bladder cancer cells.
Zheng Y; Izumi K; Yao JL; Miyamoto H
Endocr Relat Cancer; 2011 Aug; 18(4):451-64. PubMed ID: 21613411
[TBL] [Abstract][Full Text] [Related]
12. [Correlation of epidermal growth factor receptor activation to metastasis-free survival of nasopharyngeal carcinoma patients].
Yuan TZ; Li XX; Cao Y; Qian CN; Zeng MS; Guo X
Ai Zheng; 2008 May; 27(5):449-54. PubMed ID: 18479591
[TBL] [Abstract][Full Text] [Related]
13. EGFR nuclear import in gallbladder carcinoma: nuclear phosphorylated EGFR upregulates iNOS expression and confers independent prognostic impact.
Li CF; Fang FM; Wang JM; Tzeng CC; Tai HC; Wei YC; Li SH; Lee YT; Wang YH; Yu SC; Shiue YL; Chu PY; Wang WL; Chen LT; Huang HY
Ann Surg Oncol; 2012 Feb; 19(2):443-54. PubMed ID: 21761100
[TBL] [Abstract][Full Text] [Related]
14. Expression of epidermal growth factor receptor, ERBB2 and KIT in adult soft tissue sarcomas: a clinicopathologic study of 281 cases.
Sato O; Wada T; Kawai A; Yamaguchi U; Makimoto A; Kokai Y; Yamashita T; Chuman H; Beppu Y; Tani Y; Hasegawa T
Cancer; 2005 May; 103(9):1881-90. PubMed ID: 15772959
[TBL] [Abstract][Full Text] [Related]
15. Expression of HER1/EGFR protein in human soft tissue sarcomas.
Yang JL; Hannan MT; Russell PJ; Crowe PJ
Eur J Surg Oncol; 2006 May; 32(4):466-8. PubMed ID: 16524687
[TBL] [Abstract][Full Text] [Related]
16. Spatial relationship of phosphorylated epidermal growth factor receptor and activated AKT in head and neck squamous cell carcinoma.
Nijkamp MM; Hoogsteen IJ; Span PN; Takes RP; Lok J; Rijken PF; van der Kogel AJ; Bussink J; Kaanders JH
Radiother Oncol; 2011 Oct; 101(1):165-70. PubMed ID: 21775008
[TBL] [Abstract][Full Text] [Related]
17. Pitfalls in immunohistochemical assessment of EGFR expression in soft tissue sarcomas.
Kersting C; Packeisen J; Leidinger B; Brandt B; von Wasielewski R; Winkelmann W; van Diest PJ; Gosheger G; Buerger H
J Clin Pathol; 2006 Jun; 59(6):585-90. PubMed ID: 16461571
[TBL] [Abstract][Full Text] [Related]
18. Activated epidermal growth factor receptor-Stat-3 signaling promotes tumor survival in vivo in non-small cell lung cancer.
Haura EB; Zheng Z; Song L; Cantor A; Bepler G
Clin Cancer Res; 2005 Dec; 11(23):8288-94. PubMed ID: 16322287
[TBL] [Abstract][Full Text] [Related]
19. Low levels of phosphorylated epidermal growth factor receptor in nonmalignant and malignant prostate tissue predict favorable outcome in prostate cancer patients.
Hammarsten P; Karalija A; Josefsson A; Rudolfsson SH; Wikström P; Egevad L; Granfors T; Stattin P; Bergh A
Clin Cancer Res; 2010 Feb; 16(4):1245-55. PubMed ID: 20145160
[TBL] [Abstract][Full Text] [Related]
20. High predictive value of epidermal growth factor receptor phosphorylation but not of EGFRvIII mutation in resected stage I non-small cell lung cancer (NSCLC).
Sonnweber B; Dlaska M; Skvortsov S; Dirnhofer S; Schmid T; Hilbe W
J Clin Pathol; 2006 Mar; 59(3):255-9. PubMed ID: 16505275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
